Sees FY23 Adjusted EBITDA: $1.2B – $1.22B. Recurring Levered Free Cash Flow: $430M – $450M. Total Capex: $610M – $650M.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IHS:
Sees FY23 Adjusted EBITDA: $1.2B – $1.22B. Recurring Levered Free Cash Flow: $430M – $450M. Total Capex: $610M – $650M.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IHS: